Stifel Financial’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.29M Buy
392,769
+57,723
+17% +$606K ﹤0.01% 1612
2025
Q4
$4.82M Buy
335,046
+14,636
+5% +$182K ﹤0.01% 1353
2025
Q3
$3.09M Buy
320,410
+9,303
+3% +$82.3K ﹤0.01% 1587
2025
Q2
$2.55M Sell
311,107
-17,859
-5% -$149K ﹤0.01% 1666
2025
Q1
$2.35M Buy
328,966
+140,122
+74% +$1.04M ﹤0.01% 1647
2024
Q4
$1.46M Buy
188,844
+39,564
+27% +$371K ﹤0.01% 2001
2024
Q3
$1.57M Buy
149,280
+17,563
+13% +$214K ﹤0.01% 1934
2024
Q2
$1.54M Buy
131,717
+41,122
+45% +$640K ﹤0.01% 1903
2024
Q1
$1.91M Buy
90,595
+22,646
+33% +$403K ﹤0.01% 1754
2023
Q4
$1.22M Buy
67,949
+2,148
+3% +$37.8K ﹤0.01% 2009
2023
Q3
$1.08M Buy
65,801
+5,824
+10% +$106K ﹤0.01% 2000
2023
Q2
$1.2M Buy
59,977
+13,678
+30% +$264K ﹤0.01% 1963
2023
Q1
$876K Buy
46,299
+12,004
+35% +$266K ﹤0.01% 2145
2022
Q4
$778K Buy
34,295
+6,497
+23% +$147K ﹤0.01% 2182
2022
Q3
$735K Buy
27,798
+2,538
+10% +$75.3K ﹤0.01% 2177
2022
Q2
$624K Buy
25,260
+4,751
+23% +$119K ﹤0.01% 2336
2022
Q1
$681K Buy
20,509
+5,626
+38% +$156K ﹤0.01% 2388
2021
Q4
$487K Buy
14,883
+3,975
+36% +$135K ﹤0.01% 2602
2021
Q3
$457K Buy
10,908
+4,669
+75% +$168K ﹤0.01% 2624
2021
Q2
$242K Buy
+6,239
New +$223K ﹤0.01% 3037

Other funds holding RGNX